Patents by Inventor Ronald E. DeGryse

Ronald E. DeGryse has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200282029
    Abstract: Methods for alleviating osteoarthritis-associated symptoms by selecting a treatment-eligible patient and local administration of a clostridial derivative, such as a botulinum toxin, to an osteoarthritis-affected site are disclosed herein.
    Type: Application
    Filed: January 17, 2020
    Publication date: September 10, 2020
    Inventors: Catherine C. Turkel, Guang-Liang Jiang, Ronald E. DeGryse
  • Patent number: 10537619
    Abstract: Methods for alleviating osteoarthritis-associated symptoms by selecting a treatment-eligible patient and local administration of a clostridial derivative, such as a botulinum toxin, to an osteoarthritis-affected site are disclosed herein.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: January 21, 2020
    Assignee: Allergan, Inc.
    Inventors: Catherine C. Turkel, Guang-Liang Jiang, Ronald E. DeGryse
  • Publication number: 20160074485
    Abstract: Methods for alleviating osteoarthritis-associated symptoms by selecting a treatment-eligible patient and local administration of a clostridial derivative, such as a botulinum toxin, to an osteoarthritis-affected site are disclosed herein.
    Type: Application
    Filed: August 31, 2015
    Publication date: March 17, 2016
    Inventors: Catherine C. Turkel, Guang-Liang Jiang, Ronald E. DeGryse